-
Zero-Shot RCT Identification Using Large Language Models: A Comparative Study With the Cochrane Classifier
Sep 9, 2025, 16:22 PM -
Health Technology Assessment Landscape for Medical Devices in Europe
Sep 9, 2025, 16:22 PM -
Budget Impact of Implementing a Case-Finding Program in UK Patients at High Risk for COPD to Explore Cost Savings Due to Earlier Diagnosis
Sep 9, 2025, 16:22 PM -
Bridging the Gap Between AI Principles and Practice: A Comparative Evaluation of AI Position Statements and Frameworks for Responsible Use
Sep 9, 2025, 16:22 PM -
Transportability of Overall Survival in Multiple Myeloma From the US to Germany: A Benchmarking Study
Sep 9, 2025, 16:22 PM -
Approaches Used in Assessing the Environmental Sustainability of Digital Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
The Costs of Loneliness-Related Health Consequences in Finland
Sep 9, 2025, 16:22 PM -
Pharmacovigilance of Cannabis-Based Products in Brazil
Sep 9, 2025, 16:22 PM -
Modeling the Long-Term Bone Health Impact of TDF/FTC PrEP in Adolescent MSM
Sep 9, 2025, 16:22 PM -
Cardiovascular Event Rate and Mortality Among Primary-Prevention Hypercholesterolemia Patients in Japan
Sep 9, 2025, 16:22 PM -
Utility of Minimum Dataset for Generation of Real-World Data in a Context With Evidence Gaps: The Left Ventricular Assist Devices as Destination Therapy
Sep 9, 2025, 16:22 PM -
Workforce Matters: Defining Labor Input for Better Health Technology Assessment
Sep 9, 2025, 16:22 PM -
The Use of Oligometastatic Disease in Routine Radiology Practice: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Incidence of Tick-Borne Encephalitis in Germany Comparison of Claims Data With Public Surveillance Data
Sep 9, 2025, 16:22 PM -
Evaluating the Acceptability of Vignette Studies in Eliciting Utility Values for Rare Diseases: Perspectives From European HTA Agencies
Sep 9, 2025, 16:22 PM -
Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study
Sep 9, 2025, 16:22 PM -
Accounting for the Additional Uncertainty Following Rank-Preserving Structural Failure Time Model (RPSFTM) Crossover Adjustment in Survival Analysis: A Sage Approach
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Delaying Type 1 Diabetes Progression: A New Cost-Effectiveness Model for Capturing the Value of Delayed Onset
Sep 9, 2025, 16:22 PM -
Fit-for-Purpose Real-World Data: Lessons From FDA QCARD and EMA Data Quality Framework
Sep 9, 2025, 16:22 PM
